Lim HW - Search Results

1

Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice.

Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Witt SA, Kimball TR, Price R, Lim HW, Molkentin JD. Sussman MA, et al. Among authors: lim hw. Cardiovasc Res. 2000 Apr;46(1):90-101. doi: 10.1016/s0008-6363(99)00422-8. Cardiovasc Res. 2000. PMID: 10727657

2

Prevention of cardiac hypertrophy in mice by calcineurin inhibition.

Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Sussman MA, et al. Among authors: lim hw. Science. 1998 Sep 11;281(5383):1690-3. doi: 10.1126/science.281.5383.1690. Science. 1998. PMID: 9733519

3

Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Sussman MA, Welch S, Gude N, Khoury PR, Daniels SR, Kirkpatrick D, Walsh RA, Price RL, Lim HW, Molkentin JD. Sussman MA, et al. Among authors: lim hw. Am J Pathol. 1999 Dec;155(6):2101-13. doi: 10.1016/S0002-9440(10)65528-9. Am J Pathol. 1999. PMID: 10595939 Free PMC article.

4

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Lim HW, et al. J Mol Cell Cardiol. 2000 Apr;32(4):697-709. doi: 10.1006/jmcc.2000.1113. J Mol Cell Cardiol. 2000. PMID: 10756124

5

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Taigen T, De Windt LJ, Lim HW, Molkentin JD. Taigen T, et al. Among authors: lim hw. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1196-201. doi: 10.1073/pnas.97.3.1196. Proc Natl Acad Sci U S A. 2000. PMID: 10655507 Free PMC article.

6

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW 2nd, Kitsis RN, Molkentin JD. De Windt LJ, et al. Among authors: lim hw. Circ Res. 2000 Feb 18;86(3):255-63. doi: 10.1161/01.res.86.3.255. Circ Res. 2000. PMID: 10679475

7

Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.

De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. De Windt LJ, et al. Among authors: lim hw. J Biol Chem. 2000 May 5;275(18):13571-9. doi: 10.1074/jbc.275.18.13571. J Biol Chem. 2000. PMID: 10788473 Free article.

8

Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Lim HW, et al. Circulation. 2000 May 23;101(20):2431-7. doi: 10.1161/01.cir.101.20.2431. Circulation. 2000. PMID: 10821822

9

The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.

Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, Kimball TR, Molkentin JD. Bueno OF, et al. Among authors: lim hw. Circ Res. 2001 Jan 19;88(1):88-96. doi: 10.1161/01.res.88.1.88. Circ Res. 2001. PMID: 11139479

10

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, Molkentin JD. De Windt LJ, et al. Among authors: lim hw. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3322-7. doi: 10.1073/pnas.031371998. Proc Natl Acad Sci U S A. 2001. PMID: 11248077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

784 results

Search Page